[New directions in the hypotensive therapy of open-angle glaucoma (experimental and clinical research)]. / Novye napravleniia gipotenzivnoi terapii otkrytougol'noi glaukomy (éksperimental'no-klinicheskie issledovaniia).
Vestn Oftalmol
; 109(1): 3-6, 1993.
Article
em Ru
| MEDLINE
| ID: mdl-8100372
ABSTRACT
Clinical use of eye drops of a hybrid beta-alpha-adrenoblocker OF-4680 to reduce intraocular pressure has shown a high efficacy of the drug, not inferior to thymolol, for local hypotensive therapy of open-angle glaucoma. A combination of thymolol with taurin helped reduce the inhibiting effect of the beta-blocker on chamber humor secretion and simultaneously enhanced its discharge. The results evidence the desirability of correcting glutathion deficiency, detected in the patients with narrow-angle glaucoma, by lipoic acid.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Glaucoma de Ângulo Aberto
Limite:
Animals
/
Humans
Idioma:
Ru
Ano de publicação:
1993
Tipo de documento:
Article